ArticleScientific reports2025

Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy.

Nikita N Kostin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.